MicroRNAs: Small RNAs with big effects

Transplantation

Volumn 90, Issue 2, 2010, Pages 105-112

  Anglicheau, Dany ^a,b,c,d   Muthukumar, Thangamani ^a   Suthanthiran, Manikkam ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

Author keywords

Biomarker; Diagnosis; Immune Monitoring; MicroRNA; Transplantation

Indexed keywords

BETA INTERFERON; BIOLOGICAL MARKER; INTERLEUKIN 8; MESSENGER RNA; MICRORNA; MICRORNA 121; MICRORNA 142; MICRORNA 146; MICRORNA 146A; MICRORNA 147; MICRORNA 150; MICRORNA 155; MICRORNA 181A; MICRORNA 196B; MICRORNA 21; MICRORNA 223; MICRORNA 326; MICRORNA 424; MICRORNA 9; NUCLEOTIDE; RANTES; SINGLE STRANDED RNA; TOLL LIKE RECEPTOR; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADAPTIVE IMMUNITY; ALLOIMMUNITY; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BIOGENESIS; BONE MARROW CELL; CELL DIFFERENTIATION; COMPETITIVE INHIBITION; DENDRITIC CELL; DIABETIC NEPHROPATHY; DIAGNOSTIC ACCURACY; DOWN REGULATION; FIBROSING ALVEOLITIS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENOME; GRANULOCYTE; HEART MUSCLE FIBROSIS; HEMATOPOIESIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; ISCHEMIA; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; LIVER FIBROSIS; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; MOLECULAR BIOLOGY; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; RNA ANALYSIS; RNA DEGRADATION; RNA INTERFERENCE; RNA SEQUENCE; T LYMPHOCYTE; TRANSPLANTATION;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; CAENORHABDITIS ELEGANS; CONSERVED SEQUENCE; EVOLUTION, MOLECULAR; GENOME, HUMAN; HUMANS; IMMUNITY, INNATE; MICRORNAS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 77954958456     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181e913c2     Document Type: Review

References (54)

1. Shyu AB, Wilkinson MF, van Hoof A. Messenger RNA regulation: To translate or to degrade. Embo J 2008; 27: 471.
2. Grosshans H, Filipowicz W. Molecular biology: The expanding world of small RNAs. Nature 2008; 451: 414.
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843.
4. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993; 75: 855.
5. Baek D, Villen J, Shin C, et al. The impact of microRNAs on protein output. Nature 2008; 455: 64.
6. Selbach M, Schwanhausser B, Thierfelder N, et al. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58.
7. Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 2008; 9: 219.
8. Valencia-Sanchez MA, Liu J, Hannon GJ, et al. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20: 515.
9. Croce CM. Oncogenes and cancer. N Engl J Med 2008; 358: 502.
10. Diez J. Do microRNAs regulate myocardial fibrosis? Nat Clin Pract Cardiovasc Med 2009; 6: 88.
11. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281.
12. BerezikovE, CuppenE,Plasterk RH. ApproachestomicroRNA discovery. Nat Genet 2006; 38(suppl): S2.
13. Friedlander MR, Chen W, Adamidi C, et al. Discovering microRNAs from deep sequencing data using miRDeep. Nat Biotechnol 2008; 26: 407.
14. Gantier MP, Sadler AJ, Williams BR. Fine-tuningof the innate immune response by microRNAs. Immunol Cell Biol 2007; 85: 458.
15. Lodish HF, Zhou B, Liu G, et al. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008; 8: 120.
16. Pipkin ME, Monticelli S.Genomics and the immune system. Immunology 2008; 124: 23.
17. Tili E, Michaille JJ, Calin GA. Expression and function of micro-RNAs in immune cells during normalordisease state.IntJMed Sci 2008;5:73.
18. Xiao C, Rajewsky K. MicroRNA control in the immune system: Basic principles. Cell 2009; 136: 26.
19. O'Connell RM, Rao DS, Chaudhuri AA, et al. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111.
20. Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 2008; 451: 1125.
21. FontanaL, Pelosi E,Greco P, et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor up-regulation. Nat Cell Biol 2007; 9: 775.
22. Taganov KD, Boldin MP, Chang KJ, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481.
23. Cobb BS, Hertweck A, Smith J, et al. A role for Dicer in immune regulation. J Exp Med 2006; 203: 2519.
24. XiaoC,SrinivasanL,Calado DP,et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 2008; 9: 405.
25. Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129: 147.
26. Rodriguez A, Vigorito E, Clare S, et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007; 316: 608.
27. Chong MM, Rasmussen JP, Rudensky AY, et al. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 2008; 205: 2005.
28. Liston A, Lu LF, O'Carroll D, et al. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 2008; 205: 1993.
29. Zhou X, Jeker LT, Fife BT, et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 2008; 205: 1983.
30. Koralov SB, Muljo SA, Galler GR, et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008; 132: 860.
31. Xiao C, Calado DP, Galler G, et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131: 146.
32. VigoritoE,Perks KL, Abreu-GoodgerC, et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 2007; 27: 847.
33. Sheedy FJ, O'Neill LA. Adding fuel to fire: MicroRNAs as a new class of mediators of inflammation. Ann Rheum Dis 2008; 67(suppl 3): iii50.
34. Kasashima K, Nakamura Y, Kozu T. Altered expression profiles of mi-croRNAs during TPA-induced differentiation of HL-60 cells. Biochem Biophys Res Commun 2004; 322: 403.
35. Anglicheau D, Sharma VK, Ding R, et al. MicroRNA expression profiles predictive ofhuman renal allograft status.Proc Natl Acad Sci USA2009; 106: 5330.
36. Wiesen JL, Tomasi TB. Dicer is regulated by cellular stresses and inter-ferons. Mol Immunol 2009; 46: 1222.
37. Liu J, Drescher KM, Chen XM. MicroRNAs and epithelial immunity. Int Rev Immunol 2009; 28: 139.
38. Perry MM, Moschos SA, Williams AE, et al. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells.J Immunol 2008; 180: 5689.
39. Gong AY, Zhou R, Hu G, et al. MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes. J Immunol 2009; 182: 1325.
40. Chen Y, Zhang J, Li J, et al. Expression of B7-H1 in inflammatory renal tubular epithelial cells. Nephron Exp Nephrol 2006; 102: e81.
41. Jiang X, Tsitsiou E, Herrick SE, et al. MicroRNAs and the regulation of fibrosis. FEBS J 2010; 277: 2015.
42. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593.
43. Park SM, Gaur AB, LengyelE, et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repres-sors ZEB1 and ZEB2. Genes Dev 2008; 22: 894.
44. Matkovich SJ, Wang W, Tu Y, et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 2010; 106: 166.
45. Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases. World J Gastroenterol 2009; 15: 5633.
46. Kato M, Zhang J, Wang M, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci USA 2007; 104: 3432.
47. Kato M, Putta S, Wang M, et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 2009; 11: 881.
48. WangQ,WangY,Minto AW,et al. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J 2008; 22: 4126.
49. Sui W, Dai Y, Huang Y, et al. Microarray analysis of microRNA expression in acute rejection after renal transplantation. Transpl Immunol 2008; 19: 81.
50. Castanotto D, Rossi JJ. The promises and pitfalls of RNA-interference- based therapeutics. Nature 2009; 457: 426.
51. Davis ME, Zuckerman JE, Choi CH, et al. Evidenceof RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010; 464: 1067.
52. Zheng X, Lian D, Wong A, et al. Novel small interfering RNA-containing solution protecting donor organs in heart transplantation. Circulation 2009; 120: 1099.
53. Zheng X, Feng B, Chen G, et al. Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am J Transplant 2006; 6: 2099.
54. Beitzinger M, Meister G. MicroRNAs: From decay to decoy. Cell 2010; 140: 612.